FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Eton Pharmaceuticals Complete Response on NDA

FDA issues Eton Pharmaceuticals a complete response letter on its NDA for dehydrated alcohol injection for treating methanol poisoning.

Federal Register

Battelle EUA Revoked for Decontamination System

Federal Register notice: FDA revokes Battelle Memorial Institutes emergency use authorization for the Battelle Critical Care Decontamination System.

Federal Register

BioFire EUA Revoked After De Novo Granted

Federal Register notice: FDA revokes a BioFire Diagnostics emergency use authorization for its BioFire Respiratory Panel 2.1 after the company was gra...

Amgen Wins Approval for Lung Cancer Therapy

FDA approves Amgens Lumakras (sotorasib) for treating adult patients with non-small cell lung cancer whose tumors have the KRAS G12C genetic mutation....

Human Drugs

Appeals Court Rules Against Homeopathic Drug Marketer

The DC Circuit Court of Appeals affirms a lower court decision recognizing FDAs authority to place homeopathic drugs on its import alert listing after...

FDA General

FDA Budget Request Seeks $477 mil. Funding Boost

FDAs fiscal year 2022 budget request seeks an 8% ($477 million) boost for agency activities.

Federal Register

FDA Reinstates Unapproved Drugs Initiative

Federal Register notice: FDA withdraws a notice by the previous administration that would have ended the agencys unapproved drugs initiative.

Federal Register

Guide on Device Post-approval Studies

Federal Register notice: FDA makes available a draft guidance entitled Procedures for Handling Post-Approval Studies Imposed by Premarket Approval App...

Federal Register

Device Postmarket Surveillance Draft Guide

Federal Register notice: FDA makes available a draft guidance entitled Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmet...

Human Drugs

Foresee Pharma NDA Approved for Prostate Cancer

FDA approves a Foresee Pharmaceuticals NDA for Camcevi (leuprolide mesylate) 42 mg for treating advanced prostate cancer.